Involvement of P2X receptors in the NAD+-induced rise in [Ca2+]i in human monocytes

Purinergic Signalling

Volumn 5, Issue 3, 2009, Pages 309-319

  Grahnert, Anja ^a   Klein, Carina ^a   Hauschildt, Sunna ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Calcium; Monocytes; NAD+; P2receptors

Indexed keywords

EID: 68349147929     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-009-9144-4     Document Type: Article

References (57)

1. Ziegler M (2000) New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 267:1550-1564 doi: 10.1046/ j.1432-1327.2000.01187.x
2. Moss J, Vaughan M (1990) ADP-ribosylating toxins and G proteins: insights into signal transduction. In: Moss J, Vaughan M (eds) American Society for Microbiology, Washington, DC
3. Berthelier V, Tixier JM, Muller-Steffner H et al (1998) Human CD38 is an authentic NAD(P)+ glycohydrolase. Biochem J 330:1383-1390
4. Aarhus R, Graeff RM, Dickey DM et al (1995) ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem 270:30327-30333 doi: 10.1074/jbc.270.51.30327
5. Galione A, Lee HC, Busa WB (1991) Ca(2+)-induced Ca2+ release in sea urchin egg homogenates: Modulation by cyclic ADP-ribose. Science 253:1143-1146 doi: 10.1126/science.1909457
6. Churchill GC, Okada Y, Thomas JM et al (2002) NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111:703-708 doi: 10.1016/S0092-8674(02)01082-6
7. 2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors. J Cell Biol 163:271-282 doi: 10.1083/jcb.200306134
8. Perraud AL, Fleig A, Dunn CA et al (2001) ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411:595-599 doi: 10.1038/35079100
9. 2+ influx system mediated by LTRPC2. Science 293:1327-1330 doi: 10.1126/ science.1062473
10. Franco L, Guida L, Bruzzone S et al (1998) The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. FASEB J 12:1507-1520
11. Guida L, Bruzzone S, Sturla L et al (2002) Equilibrative and concentrative nucleoside transporters mediate influx of extracellular cyclic ADP-ribose into 3T3 murine fibroblasts. J Biol Chem 277:47097-47105 doi: 10.1074/jbc.M207793200
12. Guida L, Franco L, Bruzzone S et al (2004) Concentrative influx of functionally active cyclic ADP-ribose in dimethyl sulfoxide-differentiated HL-60 cells. J Biol Chem 279:22066-22075 doi: 10.1074/jbc.M314137200
13. Billington RA, Bellomo EA, Floriddia EM et al (2006) A transport mechanism for NAADP in a rat basophilic cell line. FASEB J 20:521-523
14. De Flora A, Zocchi E, Guida L et al (2004) Autocrine and paracrine calcium signaling by the CD38/NAD+/cyclic ADP-ribose system. Ann N Y Acad Sci 1028:176-191
15. Verderio C, Bruzzone S, Zocchi E et al (2001) Evidence of a role for cyclic ADP-ribose in calcium signalling and neurotransmitter release in cultured astrocytes. J Neurochem 78:646-657 doi: 10.1046/ j.1471-4159.2001.00455.x
16. Esguerra M, Miller RF (2002) CD38 expression and NAD+-induced intracellular Ca+ mobilization in isolated retinal Muller cells. Glia 39:314-319 doi: 10.1002/glia.10115
17. Sun L, Adebanjo OA, Moonga BS et al (1999) CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption. J Cell Biol 146:1161-1172 doi: 10.1083/jcb.146.5.1161
18. +: A novel autocrine/paracrine signal in osteoblast physiology. Biochem Biophys Res Commun 299:424-431 doi: 10.1016/S0006-291X(02)02665-7
19. + regulates intracellular free calcium concentration in human monocytes. Biochem J 382:849-856 doi: 10.1042/BJ20040979
20. Grage-Griebenow E, Lorenzen D, Fetting R et al (1993) Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol 23:3126-3135 doi: 10.1002/ eji.1830231213
21. Grahnert A, Richter S, Siegert F et al (2008) The orthologue of the "acatalytic" mammalian ART4 in chicken is an arginine-specific mono-ADP-ribosyltransferase. BMC Mol Biol 14:86-100 doi: 10.1186/ 1471-2199-9-86
22. Lambrecht G, Friebe T, Grimm U et al (1992) PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol 217:217-219 doi: 10.1016/0014-2999(92)90877-7
23. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
24. Kaufmann A, Musset B, Limberg SH et al (2005) "Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 280:32459-32467 doi: 10.1074/jbc.M505301200
25. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471-1483 doi: 10.1007/s00018-007-6497-0
26. Bianchi BR, Lynch KJ, Touma E et al (1999) Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 376:127-138 doi: 10.1016/S0014-2999(99)00350-7
27. Di Virgilio F, Chiozzi P, Ferrari D et al (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600 doi: 10.1182/blood.V97.3.587
28. North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580 doi: 10.1146/annurev.pharmtox.40.1.563
29. Rettinger J, Braun K, Hochmann H et al (2005) Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 48:461-468 doi: 10.1016/j.neuropharm.2004.11.003
30. Gargett CE, Wiley JS (1997) The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol 120:1483-1490 doi: 10.1038/sj.bjp.0701081
31. Humphreys BD, Virginio C, Surprenant A et al (1998) Isoquinolines as antagonists of the P2X7 nucleotide receptor: High selectivity for the human versus rat receptor homologues. Mol Pharmacol 54:22-32
32. Murgia M, Hanau S, Pizzo P et al (1993) Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem 268:8199-8203
33. Buell G, Chessell IP, Michel AD et al (1998) Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92:3521-3528
34. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
35. Surprenant A, Rassendren F, Kawashima E et al (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738 doi: 10.1126/science.272.5262.735
36. Rassendren F, Buell GN, Virginio C et al (1997) The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 272:5482-5486 doi: 10.1074/jbc.272.9.5482
37. Gudipaty L, Humphreys BD, Buell G et al (2001) Regulation of P2X(7) nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol Cell Physiol 280:C943-C953
38. Khakh BS, Proctor WR, Dunwiddie TV et al (1999) Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 19:7289-7299
39. Ziegler M (2005) A vital link between energy and signal transduction. FEBS J 272:4561-4564 doi: 10.1111/j.1742-4658.2005.04893.x
40. 2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. J Biol Chem 272:8546-8550 doi: 10.1074/jbc.272.13.8546
41. Guse AH, da Silva CP, Berg I et al (1999) Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 398:70-73 doi: 10.1038/18024
42. + is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem 281:31419-31429 doi: 10.1074/jbc.M606625200
43. Seman M, Adriouch S, Scheuplein F et al (2003) NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19:571-582 doi: 10.1016/ S1074-7613(03)00266-8
44. Priel A, Silberberg SD (2004) Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 123:281-293 doi: 10.1085/ jgp.200308986
45. Dubyak GR (2001) Role of P2 receptors in the immune system. In: Abbracchio MP, Williams M (eds) Purinergic and pyrimidinergic signalling II. Springer, Berlin
46. Falzoni S, Munerati M, Ferrari D et al (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95:1207-1216 doi: 10.1172/JCI117770
47. Hickman SE, el Khoury J, Greenberg S et al (1994) P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood 84:2452-2456
48. Gu BJ, Zhang WY, Bendall LJ et al (2000) Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: Evidence for nonfunctional P2X(7) receptors. Am J Physiol Cell Physiol 279:C1189-C1197
49. Michel AD, Chessell IP, Humphrey PP (1999) Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol 359:102-109 doi: 10.1007/PL00005328
50. Nuttle LC, Dubyak GR (1994) Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes. J Biol Chem 269:13988-13996
51. Wiley JS, Chen R, Wiley MJ et al (1992) The ATP4- receptor-operated ion channel of human lymphocytes: Inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions. Arch Biochem Biophys 292:411-418 doi: 10.1016/0003-9861(92)90010-T
52. Virginio C, MacKenzie A, North RA et al (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 519:335-346 doi: 10.1111/j.1469-7793.1999.0335m.x
53. Schilling WP, Wasylyna T, Dubyak GR et al (1999) Maitotoxin and P2Z/ P2X(7) purinergic receptor stimulation activate a common cytolytic pore. Am J Physiol 277:C766-C776
54. Jiang LH, Rassendren F, MacKenzie A et al (2005) N -methyl- d -glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am J Physiol Cell Physiol 289:C1295-C1302 doi: 10.1152/ ajpcell.00253.2005
55. Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082 doi: 10.1038/sj.emboj.7601378
56. Pfister M, Ogilvie A, da Silva CP et al (2001) NAD degradation and regulation of CD38 expression by human monocytes/macrophages. Eur J Biochem 268:5601-5608 doi: 10.1046/j.1432-1033.2001.02495.x
57. Haag F, Adriouch S, Braß A et al (2007) Extracellular NAD and ATP: partners in immune cell modulation. Purinergic Signal 3:71-81 doi: 10.1007/s11302-006-9038-7